1.Peripheral T Cell Lymphoma Associated with Hemophagocytic Histiocytosis Mimicking Malignant Histiocytosis.
Hye Ryoung YOON ; Young Hyeh KO ; Sun Hee KIM
Korean Journal of Clinical Pathology 1997;17(6):934-943
BACKGROUND: Peripheral T cell lymphoma (PTCL), a prevalent form of non Hodgkin lymphomas in East Asia, can manifest fever, hepatomegaly, lymphadenopathy, pancytopenia and hemophagocytic histiocytosis (HPH). Similar clinicopathologic findings are also frequently encountered in reactive hemophagocytic syndrome (HPS) and malignant histiocytosis (MH) , thus diagnoses could be confused among them. With recent advancement of immunohistochemlal techniques, diagnostic accuracies have been improved and most cases of MH could have been reclassified as PTCL. In this study, we intended to delineate the lineage of atypical malignant cells in bone marrow of subjects which were previously diagnosed as MH or HPS with immunohlstochemical analysis and characterize clinlcophathologic findings of PTCL associated with HPH in the bone marrow. METHODS: Five cases dignosed as HPS, 3 as MH, 3 as presumed MH, and 7 as PTCL on bone marrow examination were enrolled in this study. We performed immunohistochemical stain for CD45, CD3, CD43, CD2O and CD68, then revised the diagnoses and summarized the clinical and morphologic features of PTCL associated with HPH. RESULTS: Eleven out of 18 cases were confirmed as PTCL which were previously diagnosed as MH(1), presumed MH(3) and PTCL(7). Eight cases of 11 PTCL showed HPH mimicking MH with infiltration of the atypical malignant cells, even if the proportion of atypical malignant cells was small on bone marrow aspirates. They manifested fever and hepatomegaly but didn't have lymphadenopathy at the early stage of disease. Subtypes of PTCL with HPH were PTCL, unspecifed (3), angioimmunoblastic T cell lymphoma (1) and undetermined (4). They showed poorer outcome in 3-month survival rate (25%) than in those with PTCL without HPH(100%). CONCLUSION: These results suggest that PTCL associated with HPH should be excluded from MH by immunohistochemical analysis. Considering that prognosis of PTCL with HPH is very poor, accurate and rapid diagnosis is needed for prompt treatment.
Bone Marrow
;
Bone Marrow Examination
;
Diagnosis
;
Far East
;
Fever
;
Hepatomegaly
;
Histiocytic Sarcoma*
;
Histiocytosis*
;
Lymphatic Diseases
;
Lymphohistiocytosis, Hemophagocytic
;
Lymphoma, Non-Hodgkin
;
Lymphoma, T-Cell
;
Lymphoma, T-Cell, Peripheral*
;
Pancytopenia
;
Prognosis
;
Survival Rate
2.In Vitro High-Resolution Sonography of Benign and Malignant Lymph Nodes: A Sonographic-Pathologic Correlation.
Young Tae KO ; Yup YOON ; Mi Jin SONG
Journal of the Korean Radiological Society 1994;31(5):915-920
PURPOSE: In vitro sonography of lymph nodes was performed to ascertain the differential point between benignancy and malignancy. MATERIALS AND METHODS: Ninty-one lymph nodes were obtained at gastric cancer surgery and pathologically proved as benignancy in 68 and malignancy in 23 cases. Sohographic and pathologic correlation of resected ninty one lymph nodes was done in terms of size, the ratio of longest diameter versus shortest diameter, central hyperechogenicity, and peripheral cortical echo. RESULTS: Sonographic findings of benign lymph node were small size, oval shape(85%), narrow central high echogenicity(44%), and symmetric cortical thickening(41%). Sonographic findings of malignant lymph node were large size, round contour(39%), loss of central high echogenicity(82%), and diffuse increase of cortical thickness(82%). CONCLUSION: The most reliable sonographic criterion for differentiation of benignancy from malignancy was size of a lymphnode.
Lymph Nodes*
;
Stomach Neoplasms
;
Ultrasonography
3.A clinical and electrophysiologic atudy of Carpal Tunnel syndrome.
Sae Yoon KANG ; Young Jin KO ; Hye Won KIM
Journal of the Korean Academy of Rehabilitation Medicine 1991;15(2):41-47
No abstract available.
Carpal Tunnel Syndrome*
4.The Prognostic Difference between the Invasive Bladder Cancer at the Initial Diagnosis and the Invasive Bladder Cancer Progressed from Superficial.
Jeong Kyun YEO ; Young Su KO ; Young Hwii KO ; Duck Ki YOON
Korean Journal of Urology 2002;43(2):112-116
PURPOSE: This study evaluated the prognostic differences in invasive cancer that progressed from a superficial transitional cell carcinoma (TCC) compared to an already invasive TCC at the time of the initial presentation. MATERIALS AND METHODS: Seventy-one patients who had a radical cystectomy performed for an invasive TCC were enrolled in this study. They were divided into two groups. In the first group, the patients were diagnosed as a superficial TCC at initially, which progressed to an invasive tumor. The second group consisted of patients who were diagnosed with invasive TCC at the time of the initial diagnosis. Two groups were compared with regard to the TNM stage, Ash grade, presence of accompanying carcinoma in-situ and survival rate. RESULTS: The group with invasive cancer at the time of the initial presentation had a significantly higher grade than the progressed group. The five-year survival rate was lower in the progressed group. Moreover, Kaplan-Meier analysis showed it was statistically significant (p=0.04). CONCLUSIONS: The grade was higher and the five-year survival rate was lower in the group with invasive cancer at the time of the initial presentation. Therefore, the invasive TCC at the initial diagnosis might take a more aggressive nature than the progressed group.
Carcinoma, Transitional Cell
;
Cystectomy
;
Diagnosis*
;
Humans
;
Kaplan-Meier Estimate
;
Prognosis
;
Survival Rate
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*
5.Clinocopathological study about malignant potentiality of gall-bladder adenoma.
Yong Sik KIM ; Young Gwan KO ; Sung Wha HONG ; Choong YOON ; Yoon Wha KIM
Journal of the Korean Surgical Society 1993;45(2):240-248
No abstract available.
Adenoma*
6.Changes in ventricular repolarization after balloon valvuloplasty in patients with pulmonary stenosis.
Jae Kon KO ; So Young YOON ; Young Hwee KIM ; In Sook PARK
Korean Circulation Journal 2001;31(3):341-346
BACKGROUND: Alterations in ventricular loading conditions lead to changes in action potential duration via mechanoelectrical feedback. A decrease in load immediately leads to prolongation of repolarization. QT interval and QT dispersion were measured to determine the long-term effect of changes in ventricular systolic load on the ventricular repolarization. METHOD: Corrected QT interval and QT dispersion were measured in 26 patients before and 3-6 months after valvuloplasty for pulmonary stenosis. To determine the effect of ventricular load on ventricular repolarization, patients were divided in 2 groups; Group 1 was those patients with a greater than 30 mmHg and Group 2 was those patients with a less than 30 mmHg decrease in right ventricular systolic pressure. RESULTS: Corrected QT interval (412.6+/-14.5 msec vs 426.4+/-16.8 msec, p < 0.05) and QT dispersion (35.0+/-7.3 msec vs 45.7+/-14..1 msec, p < 0.05)were increased significantly only in Group 1 after vlavuloplasty. CONCLUSION: It suggested that mechanoelectrical interactions are operative for long duration in humans that changes in ventricular load after successful pulmonary valvuloplasty showed long-term effect on the ventricular repolarization.
Action Potentials
;
Balloon Valvuloplasty*
;
Blood Pressure
;
Humans
;
Pulmonary Valve Stenosis*
7.Additional lesions seen in magnetic resonance imaging of breast cancer patients: the role of second-look ultrasound and imaging-guided interventions.
So Yoon PARK ; Boo Kyung HAN ; Eun Sook KO ; Eun Young KO ; Eun Yoon CHO
Ultrasonography 2019;38(1):76-82
PURPOSE: The purpose of this study was to investigate the final outcomes of magnetic resonance imaging (MRI)-identified additional lesions (MRALs) in breast cancer patients and the role of second-look ultrasound (SLUS) and imaging-guided interventions. METHODS: We analyzed breast cancer patients with MRALs on preoperative MRI between January and June 2012. MRALs were defined as additional lesions suspected on MRI but not suspected on mammograms or ultrasound. The malignancy rate of MRALs, MRI-based Breast Imaging Reporting and Database System (BI-RADS) category, positional relationship with the index cancer, MRI-concordant lesion visibility on SLUS, performance of imaging-guided interventions, and total mastectomy (TM) rates were evaluated for the confirmed lesions. RESULTS: Among the 119 confirmed lesions, SLUS and imaging-guided interventions were performed in 94 (79.0%) and 82 cases (68.9%), respectively. The malignancy rate was 68.1% (81 of 119), and was significantly higher in BI-RADS 4C-5 lesions than in 4A-4B lesions (94.6% vs. 56.1%, P < 0.01) and in ipsilateral same-quadrant lesions than in contralateral lesions (84.2% vs. 33.3%, P < 0.01). The lesion visibility rate on SLUS was 90.4%. The malignancy rate was not significantly different according to lesion visibility on SLUS. The TM rate in the 98 cases with ipsilateral MRALs was 37.8%, while it was significantly lower in patients who underwent an imaging-guided intervention than in those who did not (27.9% vs. 54.1%, P=0.017). CONCLUSION: MRALs show a high probability of malignancy, especially if they are ipsilateral. SLUS and imaging-guided interventions can eliminate many unnecessary TMs.
Breast Neoplasms*
;
Breast*
;
Humans
;
Magnetic Resonance Imaging*
;
Mastectomy, Simple
;
Ultrasonography*
8.Spiral CT of the Gastric Adenocarcinoma.
Dong Ho LEE ; Young Tae KO ; Yup YOON
Journal of the Korean Radiological Society 1997;37(1):123-128
CT has an important role in the evaluation of gastric adenocarcinoma. It clearly demonstrates the primary tumor itself and reveals the spread of cancer to adjacent or distant structures. It is therefore useful in the staging of gastric carcinoma, and has proved valuable in the differential diagnosis of this and other gastrictumors. Recent advances in technology such as spiral CT with water ingestion, improve the value of CT. This report describes the characteristic findings of gastric adenocarcinomas by spiral CT, and elucidates its role in the staging of gastric carcinoma.
Adenocarcinoma*
;
Diagnosis, Differential
;
Eating
;
Tomography, Spiral Computed*
;
Water
9.Budd-Chiari syndrome by membranous obstruction of inferior vena cava: comparison of sonography and computed tomography.
Dong Ho LEE ; Jae Hoon LIM ; Young Tae KO ; Yup YOON ; Joo Won LIM
Journal of the Korean Radiological Society 1992;28(3):387-392
Membranous obstruction of the hepatic inferior vena cava(MOVC)is one of the common causes of Budd-Chiari syndrome. The aim of this study is to ascertain and compare the characteristic sonographic and CT findings of Budd-Chiari syndrome caused by MOVC. We studied 10 patients of Budd-Chiari syndrome caused by MOVC through sonography and CT. MOVC was confirmed by operation and/or inferior vena cavography. The cases included 9 men and one woman. With sonography. IVC obstruction was diagnosed in 9 cases. The cause of IVC obstruction was web in 5 cases and fibrous cord in 3 cases. The cause was unspecified in on case. Obliteration of the hepatic veins and intrahepatic collateral vessels were delineated in 9 cases. With color doppler sonography, the directions of blood flow of the hepatic veins through the intervenous communication were fairly well demonstrated in all 5 cases. With CT, IVC obstruction was diagnosed in 7 cases. The obliteration of the hepatic segment of the IVC were segmental in 6 cases and diffuse in one case. Ct demonstrated communicating vessels between the hepatic veins in 3 cases. Furthermore. Systemic collateral vessls(azygos and hemiazygos veins. Veins along the abdominal wall, and internal mammary veins)were demonstrated in all cases. Liver cirrhosis was combined in all cases and hepatoma developed in 4 cases. Sonography is useful to detect the MOVC and to demonstrate hepatic venous obstruction and intrahepatic collateral vessels. Color doppler sonography is easily performed to show the direction of the blood flow through interconnecting vessels. CT shows the obliterated segment of the IVC clearly and multiple prominent systemic coliaterals. In conclusion, and Budd-Chiai syndrome caused by MOVC is accurately diagnosed by combined color doppler sonography and CT.
Abdominal Wall
;
Budd-Chiari Syndrome*
;
Carcinoma, Hepatocellular
;
Female
;
Hepatic Veins
;
Humans
;
Liver Cirrhosis
;
Male
;
Ultrasonography
;
Veins
;
Vena Cava, Inferior*
10.The Value of Squamous Cell Carcinoma Antigen as a Predictor of Nodal Metastasis in Cervical Cancer.
Chang Soo PARK ; Hyeong Kweon KO ; Gi Joo KANG ; Man Soo YOON ; Mee Young SOL
Korean Journal of Obstetrics and Gynecology 2000;43(3):418-422
OBJECTIVE: The clinical value of preoperative serum squamous cell carcinoma antigen(SCC) in relation to clinical stage, tumor volume, disease extent and prognosis has already reported in many papers. The aim of this study is to analyse the relationship between preoperative SCC level and pelvic lymph node metastasis. Matrials and METHODS: From March 1995 to December 1998, 157 patients who examined pretreatment SCC levels before undergoing radical hysterectomy for squamous cell carcinoma of uterine cervix were included. The effect of pelvic lymph node status on the SCC level was examined by comparing 125 cases with cancer limited uterus or upper vagina and 32 cases with cancer confined to the uterus (including upper vagina) and pelvic lymph node using multivariate analysis. RESULTS: 90% of patients without pelvic lymph node metastasis showed SCC levels of 2.9ng/ml or below. 60.7% of patients with serum SCC level more than 2.9ng/ml exhibited pelvic lymph node metastasis. The marker values exceeding 2.9ng/ml increased risk of nodal metastasis 5 times compared with serum level 2.9ng/ml or below. Multivariate analysis confirmed that the pelvic lymph node metastasis had a large impact on the marker level than did tumor size or depth of stromal infilteration. CONCLUSION: SCC levels greater than 2.9ng/ml can be considered a high risk zone for nodal metastasis
Carcinoma, Squamous Cell*
;
Cervix Uteri
;
Female
;
Humans
;
Hysterectomy
;
Lymph Nodes
;
Multivariate Analysis
;
Neoplasm Metastasis*
;
Prognosis
;
Tumor Burden
;
Uterine Cervical Neoplasms*
;
Uterus
;
Vagina